← Eichor
Condition: Skull Base Neoplasms Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Skull Base Neoplasms

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Neurocognition After Radiotherapy in CNS- and Skull-base Tumors
NA · 3 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT05727605Role of Novel RADA16 Hydrogel in Endoscopic Skull Base Surgery
NA · 1 location(s) · Indiana University · NCT05898074Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-esca
Phase 2 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT07209189The Impact of Endoscopic Endonasal Skull Base Surgery on Olfaction
Phase N/A · 3 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT06874426NoSeal Trial: Comparing Sealants Versus No Sealant for Preventing CSF Leak After Endonasal Skull Base Surgery
NA · 1 location(s) · Maria Sklodowska-Curie National Research Institute of Oncolo · NCT07216157Application of Augmented Reality Neuronavigation in Transnasal Endoscopic Skull Base Surgery
NA · 1 location(s) · The First Affiliated Hospital of Xiamen University · NCT06282224Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base
NA · 1 location(s) · Quironsalud · NCT05861245AI Recognition of Important Structures in Otolaryngological Surgery
Phase N/A · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT06726551Molecular and Cellular Characterization of Skull Base Tumors
Phase N/A · 1 location(s) · University of Pittsburgh · NCT03759717Postoperative Complications Following Skull Base Tumor Resection
Phase N/A · 1 location(s) · Beijing Tiantan Hospital · NCT06587906Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin
Phase 2 · 1 location(s) · Ayal A. Aizer, MD · NCT07132190Neurosurgical Outcome Network
Phase N/A · 27 location(s) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · NCT06724029Deep Learning-based sbORN Diagnostic Model
Phase N/A · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT06463392Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06176989Cognitive Status After Removal of Skull Base Meningioma
Phase N/A · 1 location(s) · Ohio State University · NCT04635657Neurocognitive Impact of Different Irradiation Modalities for Patients With Grade I-II Skull Base Meningioma:
NA · 3 location(s) · Centre Francois Baclesse · NCT06036706Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral
Phase 4 · 1 location(s) · M.D. Anderson Cancer Center · NCT04265430Prospective Study of Sinonasal and Skull-base Tumours Management
Phase N/A · 1 location(s) · University Medical Centre Ljubljana · NCT05607888Efficacy and Safety Evaluation of Absorbable and Moldable Skull Base Support Plates in Extended Endoscopic Endonasal Tra
Phase 2 · 8 location(s) · Nanfang Hospital, Southern Medical University · NCT07539792HRQoL in Patients With Solid Tumors Treated With Hadrontherapy
Phase N/A · 1 location(s) · CNAO National Center of Oncological Hadrontherapy · NCT05947149Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT05733091
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.